Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CARM1 | Q86X55 | 1/20 | 0.59 |
| ▸ | PRMT6 | Q96LA8 | 1/20 | 0.59 |
| ▸ | PRMT8 | Q9NR22 | 1/20 | 0.59 |
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.56 |
| ▸ | SIGMAR1 | Q99720 | 3/20 | 0.55 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.52 |
| ▸ | DPP7 | Q9UHL4 | 1/20 | 0.52 |
| ▸ | CA12 | O43570 | 3/20 | 0.50 |
| ▸ | CA1 | P00915 | 3/20 | 0.50 |
| ▸ | CA2 | P00918 | 3/20 | 0.50 |
| ▸ | CA9 | Q16790 | 3/20 | 0.50 |
| ▸ | KDM1A | O60341 | 1/20 | 0.46 |
| ▸ | NPC1 | O15118 | 1/20 | 0.42 |
| ▸ | MAPT | P10636 | 2/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.42 |
| ▸ | POLB | P06746 | 1/20 | 0.42 |
| ▸ | SCN5A | Q14524 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31326654 | 1.00 | CARM1 (0.59) | CARM1PRMT6PRMT8ACE2SIGMAR1 | |
| SCHEMBL10410535 | 0.97 | CARM1 (0.62) | CARM1PRMT6PRMT8ACE2SIGMAR1 | |
| SCHEMBL17526217 | 0.94 | CARM1 (0.59) | CARM1PRMT6PRMT8ACE2SIGMAR1 | |
| SCHEMBL22788741 | 0.94 | CARM1 (0.59) | CARM1PRMT6PRMT8ACE2SIGMAR1 | |
| SCHEMBL17528553 | 0.94 | CARM1 (0.59) | CARM1PRMT6PRMT8ACE2SIGMAR1 | |
| SCHEMBL6051858 | 0.92 | ACE2 (0.56) | CARM1PRMT6PRMT8ACE2SIGMAR1 | |
| SCHEMBL13661585 | 0.90 | HRH3 (0.56) | CARM1PRMT6PRMT8ACE2SIGMAR1 | |
| SCHEMBL17526226 | 0.89 | ACE2 (0.58) | CARM1PRMT6PRMT8ACE2SIGMAR1 | |
| SCHEMBL12302972 | 0.88 | CARM1 (0.54) | CARM1PRMT6PRMT8ACE2SIGMAR1 | |
| SCHEMBL8309995 | 0.88 | CARM1 (0.48) | CARM1PRMT6PRMT8ACE2SIGMAR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3033409-B1 | COMPOSITION | CATEXEL TECH LIMITED (GB) | 2021-09-22 | — | — | EP | disclosed |
| CN-107709658-B | Oxidation process | 卡特克塞尔科技有限公司 | 2021-04-09 | — | — | CN | disclosed |
| EP-3307940-B1 | OXIDATIVE METHOD | CATEXEL TECH LIMITED (GB) | 2021-03-24 | — | — | EP | disclosed |
| EP-3307941-B1 | OXIDATIVE METHOD | CATEXEL TECH LIMITED (GB) | 2021-03-24 | — | — | EP | disclosed |
| US-10882745-B2 | Oxidative method | CATEXEL TECHNOLOGIES LIMITED (GB) | 2021-01-05 | — | — | US | disclosed |
| US-10815616-B2 | Oxidative method | CATEXEL TECHNOLOGIES LIMITED (GB) | 2020-10-27 | — | — | US | disclosed |
| CN-107709533-B | Oxidation process | 卡特克塞尔科技有限公司 | 2020-09-18 | — | — | CN | disclosed |
| CN-105452432-B | Composition comprising a metal oxide and a metal oxide | 切姆森蒂有限公司 | 2020-04-28 | — | — | CN | disclosed |
| US-10370621-B2 | Bleaching formulations comprising particles and transition metal ion-containing bleaching catalysts | CHEMSENTI LIMITED (GB) | 2019-08-06 | — | — | US | disclosed |
| US-20180186634-A1 | OXIDATIVE METHOD | CATEXEL B.V. (NL) | 2018-07-05 | — | — | US | disclosed |
| US-20180094384-A1 | OXIDATIVE METHOD | CATEXEL B.V. (NL) | 2018-04-05 | — | — | US | disclosed |
| WO-2016198891-A1 | OXIDATIVE METHOD | CHEMSENTI LIMITED (GB) | 2016-12-15 | — | — | WO | disclosed |
| WO-2016198890-A1 | OXIDATIVE METHOD | CHEMSENTI LIMITED (GB) | 2016-12-15 | — | — | WO | disclosed |
| EP-3033409-A1 | COMPOSITION | Chemsenti Limited (GB) | 2016-06-22 | — | — | EP | disclosed |
| US-20160160160-A1 | COMPOSITION | CHEMSENTI LIMITED (GB) | 2016-06-09 | — | — | US | disclosed |
| WO-2015022502-A1 | COMPOSITION | CHEMSENTI LIMITED (GB) | 2015-02-19 | — | — | WO | disclosed |
| WO-2009131246-A1 | SORDARIN DERIVATIVES FOR PREVENTING OR TREATING INFECTIOUS DISEASES CAUSED BY PATHOGENIC MICROORGANISMS | ASTELLAS PHARMA INC. (JP) | 2009-10-29 | — | — | WO | disclosed |
| WO-2009131246-A1 | SORDARIN DERIVATIVES FOR PREVENTING OR TREATING INFECTIOUS DISEASES CAUSED BY PATHOGENIC MICROORGANISMS | ASTELLAS PHARMA INC. (JP) | 2009-10-29 | — | — | WO | disclosed |
| US-20060088786-A1 | Rewritable optical information recording medium, recording and reproducing methods, as well as recording and reproducing apparatus | MITSUI CHEMICALS, INC. (JP) | 2006-04-27 | — | — | US | disclosed |
| EP-1484191-A1 | REWRITABLE OPTICAL INFORMATION RECORDING MEDIUM AND RECORDING/REPRODUCING METHOD, RECORDING/REPRODUCING DEVICE | Sony Corporation (JP) | 2004-12-08 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10815616-B2 | Oxidative method | CAT, LPO, MPO | CARM1 1630/4885PRMT6 1322/4885PRMT8 1798/4885 |
| US-20060088786-A1 | Rewritable optical information recording medium, recording and reproducing methods, as well as recording and reproducing apparatus | ALPG, TRPC6, GNRHR | CARM1 1297/4885PRMT6 330/4885PRMT8 331/4885 |
| US-10882745-B2 | Oxidative method | CAT, LPO, GPX4 | CARM1 2131/4885PRMT6 2106/4885PRMT8 2559/4885 |
| US-20180094384-A1 | OXIDATIVE METHOD | CAT, LPO, MPO | CARM1 1630/4885PRMT6 1322/4885PRMT8 1798/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.